Private philanthropy has played a critical role at the Broad Institute from the very beginning. The Institute was launched thanks to the vision and generosity of two extraordinary philanthropists, Eli and Edythe Broad. Even in the early days of genomics, they understood the enormous promise of the then-emerging field, and the need to invest in it in order to realize that promise.
Transformative science usually stems from truly original—and risky—ideas. But researchers often face serious hurdles in funding their most ambitious projects precisely because of their risky nature. Thanks to the generosity and support of our philanthropic partners, the Broad is able to empower researchers to pursue their most ambitious projects. From dissecting the circuitry of cells to developing personalized cancer vaccines, our donors have provided catalytic funding for research that fundamentally changes the way we understand and treat disease.
We invite you to learn more about the impact that our donors have made.
More than 1,100 women and men across the country are taking part in an ambitious patient-driven genomic research project based at the Broad Institute: The Metastatic Breast Cancer Project.